Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
$0.00
-14.3%
$0.00
$0.00
$0.00
$1.15M0.4210.29 million shs3.83 million shs
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$0.07
C$0.08
C$0.06
C$0.12
C$26.98M0.88322,671 shs103,268 shs
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
$5.41
-6.1%
$5.45
$1.78
$6.69
N/A1.3925,095 shs300 shs
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$0.25
-3.8%
C$0.07
C$0.01
C$0.15
C$36.21M1.13626,457 shs13,500 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
0.00%-12.50%-12.50%+40.00%-22.22%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00%-7.14%-18.75%-23.53%-13.33%
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
0.00%0.00%0.00%0.00%+32.60%
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.00%-16.67%+614.29%+2,400.00%+108.33%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/AN/AN/AN/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/AN/AN/AN/A
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
N/AN/AN/AN/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
0.00
N/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00
N/AN/AN/A
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
0.00
N/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/AN/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$39.42M0.68C$0.05 per share1.30C$0.11 per share0.59
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
$46.47MN/A$0.32 per share16.80$7.69 per shareN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$2.94M12.30C$0.30 per share0.83C$0.00 per share180.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/AN/A0.00N/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
-C$12.05M-C$0.03N/AN/A-30.56%-24.41%-7.17%N/A
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
-$7.78MN/A0.00N/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
-C$7.92M-C$0.05N/AN/A-268.91%-602.73%-74.79%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/AN/AN/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/A
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
N/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/A7.35%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/AN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
1.45
3.21
3.10
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
N/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
902.05
0.80
19.71

Institutional Ownership

CompanyInstitutional Ownership
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.71%
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
N/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cavu Resources Inc. stock logo
CAVR
Cavu Resources
N/A1.91 billionN/ANot Optionable
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
130415.00 millionN/ANot Optionable
Qilian International Holding Group Limited stock logo
QLI
Qilian International Holding Group
280N/AN/ANot Optionable
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
19144.85 millionN/ANot Optionable

Recent News About These Companies

Willow Biosciences to sell operating subsidiary for $3.38M
WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY
Willow Biosciences is looking for a buyer
WLLW:CA Willow Biosciences Inc.
Willow Biosciences Inc.
Closing Bell: Willow Biosciencesinc flat on Monday (WLLW)
TSX:WLLW (Willow Biosciences Inc.)
Willow Biosciences Inc (WLLW)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cavu Resources stock logo

Cavu Resources OTCMKTS:CAVR

$0.0006 0.00 (-14.29%)
As of 02:39 PM Eastern

LiveToBeHappy, Inc. operates as a multi-platform real estate development and technology company. The company's Real Estate Development Platform focuses on developing communities and places, including homes, apartments, townhomes, and condominiums. It also provides Technology Platform, including Growing Together Academy, which provides an online curriculum solution emphasizing critical thinking and analytical skills, as well as science, technology, engineering, and mathematics competencies; and The DRIP Climber, a patent pending belt driven fitness climber, which enables in burning calories and enhancing cardiovascular function. In addition, the company offers SOKU, a social chill app to make personal connections, meet neighbors, and chill with newfound friends. Further, it acts as a residential land development, and custom single- and multi-family home builder. The company was formerly known as CAVU Resources, Inc. and changed its name to LiveToBeHappy, Inc. in July 2021. LiveToBeHappy, Inc. was incorporated in 1995 and is based in Charlotte, North Carolina.

MediPharm Labs stock logo

MediPharm Labs TSE:LABS

C$0.06 0.00 (0.00%)
As of 03:17 PM Eastern

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Qilian International Holding Group stock logo

Qilian International Holding Group NASDAQ:QLI

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Willow Biosciences stock logo

Willow Biosciences TSE:WLLW

C$0.25 -0.01 (-3.85%)
As of 07/4/2025

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.